Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626664 · ClinicalTrials.gov registry record · Phase 2
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
A Phase 2 study of Adult T-cell Leukemia-Lymphoma, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
- 20
- Study locations
NCT01626664 is a Phase 2 study of Adult T-cell Leukemia-Lymphoma that has completed, run by Kyowa Kirin. The registered enrollment target is 71 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT01626664, a Phase 2 study of Adult T-cell Leukemia-Lymphoma, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to estimate the overall response rate of subjects with relapsed or refractory Adult T-cell Leukemia-Lymphoma (ATL).
Conditions Studied
Interventions
- DRUG Pralatrexate
- BIOLOGICAL KW-0761
- DRUG gemcitabine plus oxaliplatin
- DRUG DHAP
Study Locations (20)
Other
- Cliniques Universitaires Saint-Luc - Brussels
- Hospital Universitario Professor Edgard Santos- UFBA - Salvador, Bahia
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - Sao Paulo- SP
- CHU de Fort de France - Fort de France Cedex
- Hospital Necker - Paris
- Hospital Nacional Edgardo Rebagliati Martins - Lima
- Instituto Oncologico Miraflores - Lima
- Guy's Hospital - London
- Imperial College - London
- Sandwell General Hospital - West Midlands
New York
- Memorial Sloan Kettering - New York
- Columbia Presbyterian - New York
- Weill Cornell Medical College - New York
- Montefiore Medical Center - The Bronx
California
- Cedars-Sinai Medical Center - Los Angeles
Florida
- University of Miami / Sylvester Comprehensive Cancer Center - Miami
Illinois
- Northwestern University - Chicago
Maryland
- National Cancer Institute - Bethesda
Missouri
- Washington University School of Medicine - St Louis
New Jersey
- Hackensack University Medical Center - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626664
The ClinicalTrials.gov registry entry for NCT01626664 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult T-cell Leukemia-Lymphoma appearing as the primary indexed condition, and to 4 interventions - of which Pralatrexate is the first listed.
NCT01626664 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT01626664 about?
NCT01626664 is a clinical study titled "KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)". The purpose of this study is to estimate the overall response rate of subjects with relapsed or refractory Adult T-cell Leukemia-Lymphoma (ATL).
What is the current status of trial NCT01626664?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2012-06. Estimated completion is 2018-02.
What conditions does trial NCT01626664 study?
This clinical trial studies the following conditions: Adult T-cell Leukemia-Lymphoma.
What interventions are being tested in trial NCT01626664?
The interventions under investigation include: Pralatrexate (DRUG), KW-0761 (BIOLOGICAL), gemcitabine plus oxaliplatin (DRUG), DHAP (DRUG).
Who is sponsoring clinical trial NCT01626664?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01626664 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.